Bristol-Myers Squibb (NY: BMY )

60.63 USD +0.48 (+0.80%)

Official Closing Price Updated: 7:00 PM EDT, Sep 23, 2021 Add to My Watchlist

Price and Volume

Volume	9,393,787
Open	60.40
Bid (Size)	60.63 (3)
Ask (Size)	60.72 (1)
Prev. Close	60.15
Today's Range	60.22 - 61.34
52wk Range	56.75 - 69.75
Shares Outstanding	2,222,113,553
Dividend Yield	3.23%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Health Equity and Elevating Tomorrow's Black Women Leaders

Today 5:00 EDT

Country 2 Country 4 Cancer (C2C4C) Event

September 21, 2021

Performance

YTD	-1.22%	-1.22%
1 Month	-12.05%	-12.05%
3 Month	-7.09%	-7.09%
6 Month	-2.68%	-2.68%
1 Year	+3.18%	+3.18%

More News

New Cancer Therapies Continue to Develop and Give Hope in Rapidly Improving Oncology Space

September 20, 2021

New Cancer Therapies Continue to Develop and Give Hope in Rapidly Improving Oncology Space

September 20, 2021

Early JW Therapeutics Backer Ruins Regulatory Breakthrough Party With Stake Sale

Today 15:47 EDT

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients w

September 20, 2021

XLV, ABBV, LLY, BMY: Large Outflows Detected at ETF

Today 11:55 EDT

4 Stocks Insiders Are Selling

Today 7:34 EDT

Investors Cheer Onconova's Rigosertib Combo Data In Lung Cancer Setting

September 22, 2021

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenoc

September 17, 2021

3 Cheap Healthcare Stocks to Buy Right Now

September 22, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.